Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
The anti-obesity drug market will be worth $130 billion by 2030, Goldman Sachs analysts said in a research note.
NEW YORK — Eli Lilly will spend more than $5 billion to expand an Indiana manufacturing site and eventually make more doses ...
Compared to its industry, the company has lower Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $3.12 Billion, which is 0.15x below the industry average, potentially ...
Wells Fargo analyst Mohit Bansal maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) yesterday and set a price target ...
The incident comes after a series of official investigations last year related to the issuance of fake birth certificates at a time when China is trying to boost its birth rate. Cardinal now expects ...
Nvidia (NVDA) continues to dominate the tech sector as the company's shares move past $1,100. The chip giant earned a boost ...
The Dow Jones Industrial Average (^DJI) seeks to close back above its all-time high of 40,000 in Monday's trading session, ...
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from ...